Cardiovascular Diseases Clinical Trial
Official title:
A Cohort Study of Chronic Cardiovascular Diseases in the Department of Cardiology, Peking University First Hospital
NCT number | NCT04996342 |
Other study ID # | CVDcohort |
Secondary ID | |
Status | Recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 15, 2021 |
Est. completion date | December 2025 |
This prospective cohort study aims to establish cohorts of patients with chronic cardiovascular disease, including refractory and secondary hypertension, coronary heart disease, atrial fibrillation, ventricular arrhythmias, structural heart disease, pulmonary hypertension, heart failure and rare diseases of the cardiovascular system, and patients with implantations of cardiac pacemaker, in order to dynamically describe the population characteristics, diagnosis and treatment status and long-term prognosis and analyze the factors affecting the choice of treatment plan, long-term management quality and clinical prognosis of these patients.
Status | Recruiting |
Enrollment | 10000 |
Est. completion date | December 2025 |
Est. primary completion date | December 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | This study includes 9 disease-specific cohorts. The specific inclusion and exclusion criteria are as following: 1. Refractory and secondary hypertension Inclusion Criteria: - Patients diagnosed as refractory hypertension and/or secondary hypertension - Patients willing to accept long-term follow-up and regular return visits Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients 2. Coronary heart disease Inclusion Criteria: - Patients undergoing coronary angiography and interventional therapy in the cath lab - Patients undergoing coronary angiography and functional assessment in the cath lab - Patients diagnosed as acute myocardial infarction Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients - Regular return visits not available 3. Atrial fibrillation Inclusion Criteria: - PAtrial fibrillation diagnosed by electrocardiogram or holter (duration >30 seconds) - Patients willing to accept long-term follow-up and regular return visits Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients - New-onset atrial fibrillation during the perioperative period of major surgery 4. Ventricular arrhythmias Inclusion Criteria: - Patients diagnosed as ventricular tachycardia, ventricular premature beat - Patients willing to accept long-term follow-up and regular return visits Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients - A transient cause of ventricular arrhythmia was determined by the doctor, and long-term follow-up was not required 5. Cardiac pacemaker implantation Inclusion Criteria: - Patients with permanent pacemaker implantations due to various causes (including bradycardia pacing, implantable cardioverter defibrillator, cardiac resynchronization therapy, leadless cardiac pacemaker, etc.) - Patients willing to accept long-term follow-up and regular return visits Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients 6. Structural heart disease Inclusion Criteria: - Patients diagnosed as structural heart disease, including congenital heart disease and severe valvular disease (moderate and above valvular stenosis or incomplete closure) - Patients willing to accept long-term follow-up and regular return visits Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients 7. Pulmonary hypertension Inclusion Criteria: - Patients diagnosed as pulmonary hypertension - Patients willing to accept long-term follow-up and regular return visits Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients 8. Heart failure Inclusion Criteria: - Patients diagnosed as heart failure - Patients willing to accept long-term follow-up and regular return visits Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients 9. Rare diseases of the cardiovascular system Inclusion Criteria: - Patients diagnosed as rare diseases in the catalog published by National Health Commission of the People's Republic of China - Patients willing to accept long-term follow-up and regular return visits Exclusion Criteria: - Severe diseases of other systems may affecting the life span of patients |
Country | Name | City | State |
---|---|---|---|
China | Division of Cardiology, Peking University First Hospital | Beijing | ?? |
Lead Sponsor | Collaborator |
---|---|
Peking University First Hospital |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Major Adverse Cardiovascular Events | Time to the first occurence of Any cause death, myocardial infarction, or Stroke | 5 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|